Repositorio Dspace

The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia

Mostrar el registro sencillo del ítem

dc.contributor.author Rajala, Hanna-L-M
dc.contributor.author Andersson, Emma-I
dc.contributor.author Porkka, Kimmo
dc.contributor.author Mustjoki, Satu
dc.contributor.author Olson, Thomas
dc.contributor.author Loughran, Thomas-P
dc.contributor.author Clemente, Michael-J
dc.contributor.author Maciejewski, Jaroslaw-P
dc.contributor.author Lagstrom, Sonja
dc.contributor.author Ellonen, Pekka
dc.contributor.author Zaman, Syed-Arshi-Uz
dc.contributor.author Marti, Jesus-M-López
dc.contributor.author Lundan, Tuija
dc.contributor.author Hamm, David-E
dc.contributor.author Jerez-Cayuela, Andrés
dc.date.accessioned 2026-10-20T11:27:01Z
dc.date.available 2026-10-20T11:27:01Z
dc.date.issued 2015-01-01
dc.identifier.citation Rajala HLM, Olson T, Clemente MJ, Lagstrom S, Ellonen P, Lundan T, et al. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. Haematologica. 1 de enero de 2015;100(1):91-9. doi:10.3324/haematol.2014.113142
dc.identifier.issn 0390-6078
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28509
dc.description.abstract T-cell large granular lymphocytic leukemia and chronic lymphoproliferative disorder of natural killer cells are intriguing entities between benign and malignant lymphoproliferation. The molecular pathogenesis has partly been uncovered by the recent discovery of somatic activating STAT3 and STAT5b mutations. Here we show that 43% (75/174) of patients with T-cell large granular lymphocytic leukemia and 18% (7/39) with chronic lymphoproliferative disorder of natural killer cells harbor STAT3 mutations when analyzed by quantitative deep amplicon sequencing. Surprisingly, 17% of the STAT3-mutated patients carried multiple STAT3 mutations, which were located in different lymphocyte clones. The size of the mutated clone correlated well with the degree of clonal expansion of the T-cell repertoire analyzed by T-cell receptor beta chain deep sequencing. The analysis of sequential samples suggested that current immunosuppressive therapy is not able to reduce the level of the mutated clone in most cases, thus warranting the search for novel targeted therapies. Our findings imply that the clonal landscape of large granular lymphocytic leukemia is more complex than considered before, and a substantial number of patients have multiple lymphocyte subclones harboring different STAT3 mutations, thus mimicking the situation in acute leukemia.
dc.language.iso eng
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Adult
dc.subject.mesh Aged
dc.subject.mesh Aged, 80 and over
dc.subject.mesh Antineoplastic Combined Chemotherapy Protocols/therapeutic use
dc.subject.mesh Arthritis, Rheumatoid/genetics
dc.subject.mesh Biomarkers/analysis
dc.subject.mesh Clonal Evolution/genetics
dc.subject.mesh Female
dc.subject.mesh Follow-Up Studies
dc.subject.mesh High-Throughput Nucleotide Sequencing/methods
dc.subject.mesh Humans
dc.subject.mesh Killer Cells, Natural/drug effects/metabolism/pathology
dc.subject.mesh Leukemia, Large Granular Lymphocytic/drug therapy/genetics/pathology
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh Mutation/genetics
dc.subject.mesh Neoplasm Staging
dc.subject.mesh Prognosis
dc.subject.mesh Receptors, Antigen, T-Cell, alpha-beta/genetics
dc.subject.mesh STAT3 Transcription Factor/genetics
dc.subject.mesh T-Lymphocytes/drug effects/metabolism/pathology
dc.subject.mesh Young Adult
dc.title The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 25281507
dc.relation.publisherversion http://www.haematologica.org/cgi/doi/10.3324/haematol.2014.113142
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.3324/haematol.2014.113142
dc.journal.title Haematologica


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta